Navigation Links
Curemark Appoints Preeminent Pediatrics Gastroenterologist
Date:12/18/2007

RYE, N.Y., Dec. 18 /PRNewswire/ -- Curemark's Board of Directors announced today that Steven M. Schwarz, MD, FAAP, FACN, AGAF, will join the company as a senior scientist and will serve on the company's Scientific Advisory Board. Dr. Schwarz is presently Chairman of the Department of Pediatrics at The Long Island College Hospital and Professor of Pediatrics at the State University of New York Health Science Center at Brooklyn.

"Dr. Schwartz is one of America's foremost authorities on pediatric gastroenterology," states Dr. Joan Fallon, Curemark's CEO. "Having Dr. Schwarz as an integral part of Curemark will assist the company greatly as we prepare for autism clinical trials scheduled for the early part of 2008. His vast expertise in the areas of gastroenterology and developmental disabilities is a perfect fit with Curemark's research and proprietary work in pediatric dysautonomia, autism and ADHD."

A graduate of Yale College and Columbia University's College of Physicians and Surgeons, Dr. Schwarz received his training in Pediatrics and Pediatric Gastroenterology and Nutrition at Columbia and Stanford Universities. Dr. Schwarz served on the faculty of the Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine from 1980-84, and at New York Medical College from 1984-95. At New York Medical College, he was awarded the Charles H. Revson Foundation Career Scientist Award. In 1995 he was named Distinguished Lecturer in the Graduate School of Health Sciences.

Curemark, with offices in Rye, NY, is a drug development company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of key enzymes in autistic children. She has identified and patented a series of biomarkers that delineate which autistic patients may have digestive deficiencies underlying their disease. Curemark is the first company to deliver upon the connection between a variety of conditions, including autism, ADD/ADHD, Parkinson's and others that have roots in the gastrointestinal tract. To learn more about our innovative science, visit http://www.Cure-Mark.com.

Media Contact:

Kate Taylor

914-925-3450

Investment Contact:

Ken Nanus

914-450-0816

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Curemark
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
Breaking Medicine Technology:
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
Breaking Medicine News(10 mins):